U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SEC File Number 0-25474
CUSIP Number 584-062-103
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR
For Period Ended: September 30, 1999
- ---------------------------------
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
- ---------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: N/A
- ---------------------------------
Part I - Registrant Information
- ---------------------------------
Full Name of Registrant: Medcom USA Incorporated
Former Name if Applicable: Sims Communications, Incoporated
Address of Principal Executive Office (Street and Number)
18001 Cowan, Suites C & D
City, State and Zip Code
Irvine, California 92614
<PAGE>
- ---------------------------------
Part II - Rules 12b-25(b) and (c)
- ---------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
(Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, or transition report or
portion thereof will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report or transition report on
Form l0-Q or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
- ---------------------------------
Part III - Narrative
- ---------------------------------
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, or N-SAR, or the transition report or portion thereof could not be filed
within the prescribed time period.
The Company recently filed an amendment to its registration statement on
Form S-3. Certain comments from the SEC with respect to this registration
statement pertained to the Company's 1934 Act filings on Forms 10-KSB and
10-QSB. In order to address the SEC's comments which are applicable to the
Company's reports on Form 10-QSB, additional time is needed to file the
Company's report on Form 10-QSB for the quarter ending September 30, 1999.
- ---------------------------------
Part IV - Other Information
- ---------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
William T. Hart (303) 839-0061
(Name) (Area Code) (Telephone Number)
<PAGE>
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding l2 months (or for such
shorter period that the registrant was required to file such reports) been
filed? If answer is no, identify report(s). [X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof? [ ]
Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Medcom USA, Incorporated.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: November 15, 1999 By: /s/ Michael Malet
-------------------------
Michael Malet, Vice President
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
